Alembic Pharmaceuticals is planning to raise fund by issue and allotment of Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of up to Rs 150 crore on Private Placement Basis under Tranche III. The company’s NCD committee will consider the same in the meeting to be held on March 19, 2019.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.